Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism - GBI Research Reports

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism

Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism - GBI Research Reports
Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism
Published Sep 01, 2011
98 pages — Published Sep 01, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research, the leading business intelligence provider, has released its latest research, Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism. The report provides a robust idea about patient recruitment status by geography, sponsor companies and year for all the major CVD indications. Furthermore, the report provides prevalence forecast data to 2017 for all the major CVD indications. The major indications covered in the report are hypertension, atrial fibrillation, dyslipidemia and venous thromboembolism. The report was built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Researchs team of industry experts.

There has been an increase in the number of clinical trials conducted for cardiovascular diseases (CVD) due to the high prevalence of CVD. According to the American Heart Associations (AHA) 2006 data, around 81.1 million people in the US suffer from CVD and one in every 2.9 deaths in the US is due to CVD. According to the European Heart Networks 2008 data, CVD caused 4.3 million deaths (48%) in Europe. The high prevalence and mortality rate associated with CVD has led to an increase in research and development (R&D) activity by pharmaceutical companies.

Clinical trials are one of the most critical parts of the drug development process. The various aspects involved in clinical trials, such as the implementation of technology, efficient supply chain management, proper site selection, patient recruitment and database management among others, are crucially important. Clinical trial recruitment is a time intensive process so good strategies must be followed by pharmaceutical companies for proper patient recruitment.

Efficient patient recruitment leads to a decrease in the time and cost associated with patient recruitment. At present, the rate of new drug approvals is declining as pharmaceutical companies are under intense pressure to reduce the time required for drug development. It is equally important to cut the costs of clinical trials through proper patient recruitment. The delay in recruitment time is responsible for the increase in the timeline of clinical trial completion, the increase in costs to conduct the clinical trial and a delay in the time to market. There are many barriers to participation for the patients and for investigators who enroll the patients into the trials.

To complete the trial recruitment targets set by the sponsors or clinical research organizations (CROs), proper strategies must be planned in the initial phases of the trial. This will help to save time as well as costs in reaching the optimum patient pool for statistical analysis. If the recruitment is faster in the early stages of the trial, high and low potential sites can be identified. High-recruiting sites can then be allowed by the sponsors to exceed their targets in order to compensate for low recruiting sites.

Scope

The report analyzes the clinical trial recruitment trends of pharmaceutical companies for various cardiovascular trials. Its scope includes -
- Insight on clinical trials conducted for major indications of cardiology such as hypertension, atherosclerosis, atrial fibrillation and venous thromboembolism from 2000-2009.
- The status of patient recruitment by geography, sponsor company, year and stage of development.
- Analysis on the average number of patients recruited per trial for major indications per year.
- Analysis on the average number of patients recruited per trial for major indications by stage of development.
- The prevalence population in India, China and Brazil for all major indications from 2010-2017.

Reasons to buy
&l

  
Source:
Document ID
GBIHC120MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents39
  List of Tables63
  List of Figures93
Clinical Trial Recruitment in CVD - Introduction122
  GBI Research Report Guidance131
Clinical Trial Recruitment in CVD - Overview1410
  Clinical Trials Share by Therapeutic Area, 2005-2010147
  Clinical Trials by Major Pharmaceutical Companies, 2005-2010211
  Clinical Trial and Patient Recruitment for Major Indications, 2000-2009222
Clinical Trials and Patient Recruitment for Hypertension2414
  Introduction241
  Number of Clinical Trials for Hypertension251
    Number of Clinical Trials by Phase251
    Number of Clinical Trials for Hypertension by Major Sponsors261
    Number of Clinical Trials for Hypertension by Geography271
    Number of Clinical Trials for Hypertension by Year281
  Prevalence Population for Hypertension (2010-2017)291
    Brazil291
    India301
    China311
  Patient Recruitment for Hypertension321
    Number of Patients Recruited by Phase of Clinical Trial321
    Number of Patients Recruited by Major Sponsors331
    Number of Patients Recruited by Geography341
    Number of Patients Recruited per Year351
  Average Number of Patients Recruited Per Trial361
    Average Number of Patients Recruited per Trial by Stage of Development361
    Average Number of Patients Recruited per Trial per Year371
Clinical Trials and Patient Recruitment for Atherosclerosis3814
  Introduction381
  Number of Clinical Trials for Atherosclerosis381
    Number of Clinical Trials by Phase382
    Number of Clinical Trials by Sponsor401
    Number of Clinical Trials by Geography411
    Number of Clinical Trials by Year421
  Prevalence Population for Atherosclerosis (2010-2017)431
    Brazil431
    India441
    China451
  Patient Recruitment for Atherosclerosis461
    Number of Patients Recruited By Phase of Clinical Trial461
    Number of Patients Recruited by Sponsor471
    Number of Patients Recruited by Geography481
    Number of Patients Recruited per Year491
  Average Number of Patients Recruited per Trial501
    Average Number of Patients Recruited per Trial by Stage of Development501
    Average Number of Patients Recruited per Trial per Year511
Clinical Trials and Patient Recruitment for Dyslipidemia5214
  Introduction521
  Number of Clinical Trials for Dyslipidemia521
    Number of Clinical Trials by Phase522
    Number of Clinical Trials by Major Sponsor541
    Number of Clinical Trials by Geography551
    Number of Clinical Trials by Year561
  Prevalence Population for Dyslipidemia (2010-2017)571
    Brazil571
    India581
    China591
  Patient Recruitment for Dyslipidemia601
    Number of Patients Recruited by Phase of Clinical Trial601
    Number of Patients Recruited by Major Sponsors611
    Number of Patients Recruited by Geography621
    Number of Patients Recruited per Year631
  Average Number of Patients Recruited per Trial641
    Average Number of Patients Recruited per Trial by Stage of Development641
    Average Number of Patients Recruited per Trial per Year651
Clinical Trials and Patient Recruitment for Atrial Fibrillation6614
  Introduction661
  Number of Clinical Trials for Atrial Fibrillation671
    Number of Clinical Trials by Phase671
    Number of Clinical Trials by Major Sponsors681
    Number of Clinical Trials by Geography691
    Number of Clinical Trials by Year701
  Prevalence Population for Atrial Fibrillation (2010-2017)711
    Brazil711
    India721
    China731
  Patient Recruitment for Atrial Fibrillation741
    Number of Patients Recruited by Phase of Clinical Trial741
    Number of Patients Recruited by Major Sponsors751
    Number of Patients Recruited by Geography761
    Number of Patients Recruited per Year771
  Average Number of Patients Recruited Per Trial781
    Average Number of Patients Recruited per Trial by Stage of Development781
    Average Number of Patients Recruited per Trial per Year791
Clinical Trials and Patient Recruitment for Venous Thromboembolism8014
  Introduction801
  Number of Clinical Trials for Venous Thromboembolism801
    Number of Clinical Trials by Phase802
    Number of Clinical Trials by Sponsor821
    Number of Clinical Trials by Geography831
    Number of Clinical Trials by Year841
  Prevalence Population for Venous Thromboembolism (2010-2017)851
    Brazil851
    India861
    China871
  Patient Recruitment for Venous Thromboembolism881
    Number of Patients Recruited By Phase of Clinical Trial881
    Number of Patients Recruited by Major Sponsors891
    Number of Patients Recruited By Geography901
    Number of Patients Recruited Per Year911
  Average Number of Patients Recruited per Trial921
    Average Number of Patients Recruited per Trial by Stage of Development921
    Average Number of Patients Recruited per Trial per Year931
Appendix945
  Market Definitions941
  Abbreviations941
  Research Methodology952
    Clinical Trials Overview951
    Number of Clinical Trials951
    Patient Recruitment Status961
    Prevalence of Disease in India, China and Brazil (2010-2017)961
  Coverage961
  Secondary Research961
  Primary Research971
  Expert Panel Validation971
  Contact Us971
  Disclaimer971
  Sources981

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism" Sep 01, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Cardiovascular-Diseases-Average-Patient-Recruitment-per-Trial-was-the-Highest-in-Venous-Thromboembolism-2115-250>
  
APA:
GBI Research Reports. (2011). Clinical Trial Recruitment in Cardiovascular Diseases - Average Patient Recruitment per Trial was the Highest in Venous Thromboembolism Sep 01, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Cardiovascular-Diseases-Average-Patient-Recruitment-per-Trial-was-the-Highest-in-Venous-Thromboembolism-2115-250>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.